Page last updated: 2024-08-21

indican and Atherosclerosis

indican has been researched along with Atherosclerosis in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (7.69)29.6817
2010's7 (53.85)24.3611
2020's5 (38.46)2.80

Authors

AuthorsStudies
Huang, L; Liu, L; Liu, XY; Liu, YF; Lu, C; Tang, MY; Wu, L; Zhang, C1
Carmona, A; Guerrero, F; Jimenez, MJ; Martin-Malo, A; Muñoz-Castañeda, JR; Rodriguez, M; Soriano, S1
Assefa, EG; Gezahegn, SB; He, S; Salissou, MTM; Wu, N; Yan, Q; Ying, C; Zuo, X1
Arakawa, S; Bamba, T; Fukusaki, E; Furuno, M; Katakami, N; Matsuoka, TA; Ninomiya, H; Omori, K; Shimomura, I; Takahara, M; Tsugawa, H; Yamamoto, Y1
Chen, S; Jin, W; Li, X; Lu, Z; Xie, Z; Yang, Y; Zhao, Y; Zhou, F1
Alaniz, RC; Eshghjoo, S; Jayaraman, A; Sun, Y1
Yamamoto, S1
Aikawa, E; Aikawa, M; Anderson, DG; Aster, JC; Barabási, AL; Boff, MS; Chen, M; Decano, JL; Golden, WS; Guimaraes, GC; Halu, A; Higashi, H; Iwata, H; Katsuki, S; Kauffman, KJ; Kum, AST; Kuromoto, RK; Lee, LH; Maejima, T; Nakano, T; Pestana, DVS; Sharma, A; Singh, SA; Suzuki, T1
Ito, S; Yoshida, M1
Exner, M; Gmeiner, BM; Hermann, M; Jirovetz, L; Kapiotis, S; Laggner, H; Praschberger, M; Wanner, J1
Goto, S; Kaneko, Y; Kawamura, K; Kazama, JJ; Matsuo, K; Narita, I; Takahashi, Y; Wakamatsu, T; Yamamoto, S1
Masai, N; Morita, T; Tatebe, J; Yoshino, G1
Niwa, T; Taki, K; Tsuruta, Y1

Reviews

4 review(s) available for indican and Atherosclerosis

ArticleYear
Indoxyl sulfate in atherosclerosis.
    Toxicology letters, 2023, Jul-01, Volume: 383

    Topics: Albumins; Atherosclerosis; Cardiovascular Diseases; Chronic Disease; Humans; Indican; Renal Insufficiency, Chronic; Uremia

2023
Microbiota-Mediated Immune Regulation in Atherosclerosis.
    Molecules (Basel, Switzerland), 2021, Jan-01, Volume: 26, Issue:1

    Topics: Animals; Atherosclerosis; Basic Helix-Loop-Helix Transcription Factors; Foam Cells; Gastrointestinal Microbiome; Humans; Indican; Inflammation; Methylamines; Receptors, Aryl Hydrocarbon

2021
Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
    Clinical and experimental nephrology, 2019, Volume: 23, Issue:2

    Topics: Amyloidosis; Animals; Atherosclerosis; Awards and Prizes; beta 2-Microglobulin; Humans; Indican; Lipoproteins, HDL; Macrophages; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Uremia

2019
Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
    Toxins, 2014, Feb-20, Volume: 6, Issue:2

    Topics: Animals; Atherosclerosis; Carbon; Cresols; Humans; Indican; Oxides; Renal Insufficiency, Chronic; Sulfuric Acid Esters; Toxins, Biological; Uremia

2014

Other Studies

9 other study(ies) available for indican and Atherosclerosis

ArticleYear
Uremic Toxins Induce THP-1 Monocyte Endothelial Adhesion and Migration through Specific miRNA Expression.
    International journal of molecular sciences, 2023, Aug-18, Volume: 24, Issue:16

    Topics: Atherosclerosis; Endothelial Cells; Humans; Indican; MicroRNAs; Monocytes; NF-kappa B; Tissue Adhesions; Uremic Toxins

2023
Role of Resveratrol on Indoxyl Sulfate-Induced Endothelial Hyperpermeability via Aryl Hydrocarbon Receptor (AHR)/Src-Dependent Pathway.
    Oxidative medicine and cellular longevity, 2019, Volume: 2019

    Topics: Animals; Antigens, CD; Antioxidants; Aorta; Atherosclerosis; Cadherins; Cattle; Cell Membrane Permeability; Cells, Cultured; Electric Impedance; Endothelial Cells; Indican; Oxidative Stress; Receptors, Aryl Hydrocarbon; Renal Insufficiency, Chronic; Resveratrol; Signal Transduction; src-Family Kinases

2019
Identification of Plasma Inositol and Indoxyl Sulfate as Novel Biomarker Candidates for Atherosclerosis in Patients with Type 2 Diabetes. -Findings from Metabolome Analysis Using GC/MS.
    Journal of atherosclerosis and thrombosis, 2020, Oct-01, Volume: 27, Issue:10

    Topics: Aged; Atherosclerosis; Biomarkers; Carotid Intima-Media Thickness; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Gas Chromatography-Mass Spectrometry; Humans; Indican; Inositol; Japan; Male; Metabolome; Metabolomics; Middle Aged; Myocardial Ischemia; Solvents

2020
Indoxyl sulfate promotes the atherosclerosis through up-regulating the miR-34a expression in endothelial cells and vascular smooth muscle cells in vitro.
    Vascular pharmacology, 2020, Volume: 131

    Topics: Apoptosis; Atherosclerosis; Cell Movement; Cell Proliferation; Cells, Cultured; Human Umbilical Vein Endothelial Cells; Humans; Indican; MicroRNAs; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Receptor, Notch1; Signal Transduction; Up-Regulation

2020
Uremic Toxin Indoxyl Sulfate Promotes Proinflammatory Macrophage Activation Via the Interplay of OATP2B1 and Dll4-Notch Signaling.
    Circulation, 2019, 01-02, Volume: 139, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Animals; Atherosclerosis; Calcium-Binding Proteins; Disease Models, Animal; Humans; Indican; Inflammation Mediators; Intercellular Signaling Peptides and Proteins; Intracellular Signaling Peptides and Proteins; Macrophage Activation; Macrophages; Male; Membrane Proteins; Mice; Mice, Knockout; Organic Anion Transporters; Phenotype; Plaque, Atherosclerotic; RAW 264.7 Cells; Receptors, LDL; Receptors, Notch; Renal Insufficiency, Chronic; Signal Transduction; Vascular Calcification

2019
The uremic toxin indoxyl sulfate acts as a pro- or antioxidant on LDL oxidation.
    Free radical research, 2014, Volume: 48, Issue:6

    Topics: Amidines; Antioxidants; Atherosclerosis; Copper; Hemin; Humans; Hydrogen Peroxide; Indican; Lipid Peroxidation; Lipid Peroxides; Lipoproteins, LDL; Oxidation-Reduction; Oxidative Stress; Peroxidase; Quinazolines; Renal Insufficiency, Chronic; Uremia

2014
Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate.
    Toxins, 2015, Aug-14, Volume: 7, Issue:8

    Topics: Atherosclerosis; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cell Survival; Cholesterol; Cytokines; Down-Regulation; Humans; Hydrocarbons, Fluorinated; Indican; Liver X Receptors; Macrophages; Orphan Nuclear Receptors; Reactive Oxygen Species; Renal Insufficiency, Chronic; Sulfonamides

2015
Indoxyl sulfate stimulates monocyte chemoattractant protein-1 expression in human umbilical vein endothelial cells by inducing oxidative stress through activation of the NADPH oxidase-nuclear factor-κB pathway.
    Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:10

    Topics: Atherosclerosis; Cells, Cultured; Chemokine CCL2; Endothelial Cells; Humans; Indican; NADPH Oxidases; NF-kappa B; Oxidative Stress; Renal Insufficiency, Chronic; Signal Transduction; Umbilical Veins

2010
Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients.
    American journal of nephrology, 2007, Volume: 27, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Atherosclerosis; Biomarkers; C-Reactive Protein; Cholesterol, HDL; Chromatography, High Pressure Liquid; Creatinine; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glycation End Products, Advanced; Humans; Incidence; Indican; Lysine; Male; Middle Aged; Nephelometry and Turbidimetry; Renal Dialysis; Uremia

2007